Genentech, BioNTech Pact Aims To Make Targeted Cancer Vaccines

Genentech will tap expertise of privately-held BioNTech in a collaboration aimed at developing individually tailored vaccines for use against a broad range of cancers, which the duo says offers “a new treatment paradigm” for oncology.